Debiopharm International Sa

This early-stage study tested a new oral drug called Debio 0123 in combination with the chemotherapy carboplatin. It aimed to find a safe and effective dose for adults with advanced solid tumors that had stopped responding to prior platinum-based treatments. The main goals were t…

This early-stage study tested a new, longer-acting version of a common hormone-controlling drug (octreotide). It aimed to see how the body processes the drug and if it's safe for people with acromegaly or certain gut/pancreatic tumors (GEP-NETs). The trial involved 19 participant…

This study tested a new antibiotic called afabicin against standard treatments for serious bone or joint infections caused by staph bacteria, including drug-resistant MRSA. It aimed to see if afabicin was safe and effective. The trial was stopped early and enrolled 67 participant…

This early-stage study tested a new oral drug, RP-6306, given alongside a standard chemotherapy regimen (FOLFIRI) in adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to find the safest dose, understand side effects, and see…

This early-stage study tested the safety of a new oral drug called RP-6306 when combined with the chemotherapy gemcitabine in adults with advanced solid tumors that had stopped responding to other treatments. The main goal was to find the highest dose patients could tolerate with…